Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis

Citation:

Guijosa A, Ramirez-Gamero A, Sarosiek S, et al. Blood Adv. 2025 Sep 23;9(18):4705-4715. PMID: 40674744; PMCID: PMC12466266.